C07C 335/18
Being further substituted by singly-bound oxygen atoms
Official title: being further substituted by singly-bound oxygen atoms
C07C335/18 (Being further substituted by singly-bound oxygen atoms) appears on 75 US grants and 68 published applications in this corpus.
Search patents in C07C- Granted patents
- 75
- Published applications
- 68
- Assignees
- 60
- Inventors
- 354
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 2 | 6 |
| 2003 | 4 | 6 |
| 2004 | 2 | 12 |
| 2005 | 5 | 4 |
| 2006 | 2 | 6 |
| 2007 | 3 | 2 |
| 2008 | 2 | 5 |
| 2009 | 2 | 4 |
| 2010 | 3 | 3 |
| 2011 | 2 | 2 |
| 2012 | 4 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 2 |
| 2015 | 2 | 1 |
| 2016 | 0 | 3 |
| 2017 | 1 | 3 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for tin-silver alloy electroplating comprising a complexing agent24 Feb 2026US 12,559,852 B2BASF SE
- Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith25 Jun 2024US 12,017,975 B2The University of British Columbia
- Aminoazole derivative23 Jun 2020US 10,689,354 B2Teijin Pharma Limited
- Tripodal nitrate receptor28 Aug 2018US 10,060,892 B2University of Oregon
- Substituted thioureas as heat shock protein 70 inhibitors1 Aug 2017US 9,718,770 B2Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A.China
- Chiral spirocyclic compounds and methods of preparation and use thereof17 Jul 2025US 2025/0229262 A1The Hong Kong University of Science and Technology
- Novel leukotriene b4 receptor inhibitors and use thereof27 Mar 2025US 2025/0100980 A1Dongguk University Industry-Academic Cooperation Foundation
- Composition for tin-silver alloy electroplating comprising a complexing agent22 Feb 2024US 2024/0060201 A1BASF SE
- Myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith4 May 2023US 2023/0134821 A1The University of British Columbia
- Myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith14 Apr 2022US 2022/0112157 A1The University of British Columbia
Most cited
By later US patents
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists88US 5,780,483 ASmithKline Beecham Corporation · 1998
- IL-8 receptor antagonists84US 6,005,008 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists76US 6,262,113 B1SmithKline Beecham Corporation · 2001
- Halogenated selective androgen receptor modulators and methods of use thereof72US 7,026,500 B2University of Tennessee Research Foundation · 2006